25 XP   0   0   10

Century Therapeutics Inc
Buy, Hold or Sell?

Let's analyse Century Therapeutics Inc together

PenkeI guess you are interested in Century Therapeutics Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Century Therapeutics Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Century Therapeutics Inc

I send you an email if I find something interesting about Century Therapeutics Inc.

Quick analysis of Century Therapeutics Inc (30 sec.)










What can you expect buying and holding a share of Century Therapeutics Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$2.14
Expected worth in 1 year
$0.94
How sure are you?
15.8%

+ What do you gain per year?

Total Gains per Share
$-1.19
Return On Investment
-39.8%

For what price can you sell your share?

Current Price per Share
$3.00
Expected price per share
$2.75 - $3.51
How sure are you?
50%

1. Valuation of Century Therapeutics Inc (5 min.)




Live pricePrice per Share (EOD)

$3.00

Intrinsic Value Per Share

$-11.58 - $-13.50

Total Value Per Share

$-9.45 - $-11.36

2. Growth of Century Therapeutics Inc (5 min.)




Is Century Therapeutics Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$177.8m$317m-$109.6m-52.9%

How much money is Century Therapeutics Inc making?

Current yearPrevious yearGrowGrow %
Making money-$33.3m-$31.1m-$2.1m-6.6%
Net Profit Margin-18,429.6%-2,875.3%--

How much money comes from the company's main activities?

3. Financial Health of Century Therapeutics Inc (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#274 / 995

Most Revenue
#611 / 995

Most Profit
#834 / 995

Most Efficient
#942 / 995

What can you expect buying and holding a share of Century Therapeutics Inc? (5 min.)

Welcome investor! Century Therapeutics Inc's management wants to use your money to grow the business. In return you get a share of Century Therapeutics Inc.

What can you expect buying and holding a share of Century Therapeutics Inc?

First you should know what it really means to hold a share of Century Therapeutics Inc. And how you can make/lose money.

Speculation

The Price per Share of Century Therapeutics Inc is $3. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Century Therapeutics Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Century Therapeutics Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $2.14. Based on the TTM, the Book Value Change Per Share is $-0.30 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.33 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Century Therapeutics Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.34-11.2%-0.40-13.4%-0.37-12.5%-0.31-10.5%-0.28-9.4%
Usd Book Value Change Per Share-0.08-2.8%-0.30-9.9%-0.33-11.0%0.00-0.1%0.113.8%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.08-2.8%-0.30-9.9%-0.33-11.0%0.00-0.1%0.113.8%
Usd Price Per Share4.18-3.17-6.72-7.21-6.45-
Price to Earnings Ratio-3.10--2.02--4.50--5.36--4.79-
Price-to-Total Gains Ratio-50.63--18.35--20.20--32.78--32.78-
Price to Book Ratio1.95-1.32-1.72-1.68-1.51-
Price-to-Total Gains Ratio-50.63--18.35--20.20--32.78--32.78-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share3
Number of shares333
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.300.00
Usd Total Gains Per Share-0.300.00
Gains per Quarter (333 shares)-99.38-1.08
Gains per Year (333 shares)-397.52-4.31
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-398-4080-4-14
20-795-8060-9-18
30-1193-12040-13-22
40-1590-16020-17-26
50-1988-20000-22-30
60-2385-23980-26-34
70-2783-27960-30-38
80-3180-31940-34-42
90-3578-35920-39-46
100-3975-39900-43-50

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.017.00.00.0%0.017.02.00.0%0.017.02.00.0%
Book Value Change Per Share0.04.00.00.0%1.011.00.08.3%2.012.03.011.8%3.013.03.015.8%3.013.03.015.8%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.017.00.0%0.00.019.00.0%0.00.019.00.0%
Total Gains per Share0.04.00.00.0%1.011.00.08.3%2.012.03.011.8%3.013.03.015.8%3.013.03.015.8%

Fundamentals of Century Therapeutics Inc

About Century Therapeutics Inc

Century Therapeutics, Inc., a biotechnology company, engages in the development of genetically engineered allogeneic cell therapies for the treatment of solid tumor and hematological malignancies. Its lead product candidate is CNTY-101, an allogeneic, induced pluripotent stem cells (iPSCs)-derived chimeric antigen receptors (CAR)-iNK cell therapy, under Phase 1 trials targeting CD19 for relapsed, refractory B-cell lymphoma. The company is also involved in the development of CNTY-102, a bi-specific CD19 + CD22 CAR-iT product candidate for relapsed, refractory B-cell lymphoma and other B-cell malignancies; and CNTY-107, a Nectin-4 CAR-iT targeted product candidate for Nectin-4 positive solid tumors. In addition, it has a strategic collaboration with Bristol-Myers Squibb Company to develop and commercialize up to four iNK or iT programs, including CNTY-104, a multi-specific collaboration program targeting acute myeloid leukemia; and CNTY-106, a multi-specific collaboration program for multiple myeloma. The company was incorporated in 2018 and is headquartered in Philadelphia, Pennsylvania.

Fundamental data was last updated by Penke on 2024-05-27 18:29:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Century Therapeutics Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Century Therapeutics Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Century Therapeutics Inc to the Biotechnology industry mean.
  • A Net Profit Margin of -3,282.1% means that $-32.82 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Century Therapeutics Inc:

  • The MRQ is -3,282.1%. The company is making a huge loss. -2
  • The TTM is -18,429.6%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-3,282.1%TTM-18,429.6%+15,147.5%
TTM-18,429.6%YOY-2,875.3%-15,554.3%
TTM-18,429.6%5Y-5,221.5%-13,208.1%
5Y-5,221.5%10Y-4,671.8%-549.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-3,282.1%-177.1%-3,105.0%
TTM-18,429.6%-223.7%-18,205.9%
YOY-2,875.3%-243.7%-2,631.6%
5Y-5,221.5%-392.9%-4,828.6%
10Y-4,671.8%-505.7%-4,166.1%
1.1.2. Return on Assets

Shows how efficient Century Therapeutics Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Century Therapeutics Inc to the Biotechnology industry mean.
  • -8.1% Return on Assets means that Century Therapeutics Inc generated $-0.08 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Century Therapeutics Inc:

  • The MRQ is -8.1%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -8.8%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-8.1%TTM-8.8%+0.7%
TTM-8.8%YOY-6.3%-2.5%
TTM-8.8%5Y-6.5%-2.3%
5Y-6.5%10Y-5.8%-0.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-8.1%-11.7%+3.6%
TTM-8.8%-11.7%+2.9%
YOY-6.3%-10.9%+4.6%
5Y-6.5%-12.9%+6.4%
10Y-5.8%-14.1%+8.3%
1.1.3. Return on Equity

Shows how efficient Century Therapeutics Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Century Therapeutics Inc to the Biotechnology industry mean.
  • -15.8% Return on Equity means Century Therapeutics Inc generated $-0.16 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Century Therapeutics Inc:

  • The MRQ is -15.8%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -16.4%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-15.8%TTM-16.4%+0.6%
TTM-16.4%YOY-9.9%-6.4%
TTM-16.4%5Y-9.1%-7.3%
5Y-9.1%10Y-8.1%-1.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-15.8%-14.1%-1.7%
TTM-16.4%-14.9%-1.5%
YOY-9.9%-13.5%+3.6%
5Y-9.1%-18.2%+9.1%
10Y-8.1%-19.2%+11.1%

1.2. Operating Efficiency of Century Therapeutics Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Century Therapeutics Inc is operating .

  • Measures how much profit Century Therapeutics Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Century Therapeutics Inc to the Biotechnology industry mean.
  • An Operating Margin of -3,661.9% means the company generated $-36.62  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Century Therapeutics Inc:

  • The MRQ is -3,661.9%. The company is operating very inefficient. -2
  • The TTM is -16,155.7%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-3,661.9%TTM-16,155.7%+12,493.8%
TTM-16,155.7%YOY-2,982.7%-13,173.0%
TTM-16,155.7%5Y-4,711.3%-11,444.4%
5Y-4,711.3%10Y-4,215.4%-495.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-3,661.9%-344.6%-3,317.3%
TTM-16,155.7%-235.7%-15,920.0%
YOY-2,982.7%-263.2%-2,719.5%
5Y-4,711.3%-384.5%-4,326.8%
10Y-4,215.4%-485.1%-3,730.3%
1.2.2. Operating Ratio

Measures how efficient Century Therapeutics Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 37.62 means that the operating costs are $37.62 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Century Therapeutics Inc:

  • The MRQ is 37.619. The company is inefficient in keeping operating costs low. -1
  • The TTM is 179.161. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ37.619TTM179.161-141.543
TTM179.161YOY33.376+145.785
TTM179.1615Y52.149+127.012
5Y52.14910Y46.761+5.388
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ37.6193.091+34.528
TTM179.1613.312+175.849
YOY33.3763.564+29.812
5Y52.1494.839+47.310
10Y46.7616.187+40.574

1.3. Liquidity of Century Therapeutics Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Century Therapeutics Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 12.44 means the company has $12.44 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Century Therapeutics Inc:

  • The MRQ is 12.438. The company is very able to pay all its short-term debts. +2
  • The TTM is 9.818. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ12.438TTM9.818+2.620
TTM9.818YOY12.800-2.982
TTM9.8185Y10.389-0.571
5Y10.38910Y9.296+1.094
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ12.4383.772+8.666
TTM9.8183.970+5.848
YOY12.8004.980+7.820
5Y10.3895.974+4.415
10Y9.2966.348+2.948
1.3.2. Quick Ratio

Measures if Century Therapeutics Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Century Therapeutics Inc to the Biotechnology industry mean.
  • A Quick Ratio of 20.99 means the company can pay off $20.99 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Century Therapeutics Inc:

  • The MRQ is 20.991. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 16.188. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ20.991TTM16.188+4.803
TTM16.188YOY21.419-5.232
TTM16.1885Y16.720-0.532
5Y16.72010Y14.960+1.760
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ20.9913.186+17.805
TTM16.1883.583+12.605
YOY21.4194.835+16.584
5Y16.7205.813+10.907
10Y14.9606.343+8.617

1.4. Solvency of Century Therapeutics Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Century Therapeutics Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Century Therapeutics Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.49 means that Century Therapeutics Inc assets are financed with 49.0% credit (debt) and the remaining percentage (100% - 49.0%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Century Therapeutics Inc:

  • The MRQ is 0.490. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.458. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.490TTM0.458+0.031
TTM0.458YOY0.363+0.095
TTM0.4585Y0.557-0.099
5Y0.55710Y0.568-0.012
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4900.337+0.153
TTM0.4580.348+0.110
YOY0.3630.286+0.077
5Y0.5570.365+0.192
10Y0.5680.377+0.191
1.4.2. Debt to Equity Ratio

Measures if Century Therapeutics Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Century Therapeutics Inc to the Biotechnology industry mean.
  • A Debt to Equity ratio of 95.9% means that company has $0.96 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Century Therapeutics Inc:

  • The MRQ is 0.959. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.852. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.959TTM0.852+0.107
TTM0.852YOY0.573+0.280
TTM0.8525Y0.936-0.083
5Y0.93610Y1.074-0.138
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9590.390+0.569
TTM0.8520.425+0.427
YOY0.5730.371+0.202
5Y0.9360.445+0.491
10Y1.0740.474+0.600

2. Market Valuation of Century Therapeutics Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Century Therapeutics Inc generates.

  • Above 15 is considered overpriced but always compare Century Therapeutics Inc to the Biotechnology industry mean.
  • A PE ratio of -3.10 means the investor is paying $-3.10 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Century Therapeutics Inc:

  • The EOD is -2.223. Based on the earnings, the company is expensive. -2
  • The MRQ is -3.097. Based on the earnings, the company is expensive. -2
  • The TTM is -2.024. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-2.223MRQ-3.097+0.874
MRQ-3.097TTM-2.024-1.074
TTM-2.024YOY-4.500+2.476
TTM-2.0245Y-5.359+3.335
5Y-5.35910Y-4.795-0.564
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-2.223-2.432+0.209
MRQ-3.097-2.855-0.242
TTM-2.024-2.845+0.821
YOY-4.500-3.439-1.061
5Y-5.359-6.200+0.841
10Y-4.795-6.453+1.658
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Century Therapeutics Inc:

  • The EOD is -2.026. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -2.823. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -2.646. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-2.026MRQ-2.823+0.797
MRQ-2.823TTM-2.646-0.177
TTM-2.646YOY-4.164+1.517
TTM-2.6465Y-3.896+1.249
5Y-3.89610Y-3.486-0.410
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-2.026-3.121+1.095
MRQ-2.823-3.560+0.737
TTM-2.646-3.575+0.929
YOY-4.164-4.801+0.637
5Y-3.896-7.936+4.040
10Y-3.486-8.480+4.994
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Century Therapeutics Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 1.95 means the investor is paying $1.95 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Century Therapeutics Inc:

  • The EOD is 1.403. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.955. Based on the equity, the company is underpriced. +1
  • The TTM is 1.317. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.403MRQ1.955-0.552
MRQ1.955TTM1.317+0.637
TTM1.317YOY1.723-0.406
TTM1.3175Y1.682-0.365
5Y1.68210Y1.505+0.177
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD1.4032.032-0.629
MRQ1.9552.149-0.194
TTM1.3172.202-0.885
YOY1.7232.466-0.743
5Y1.6823.727-2.045
10Y1.5054.178-2.673
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Century Therapeutics Inc.

3.1. Institutions holding Century Therapeutics Inc

Institutions are holding 54.459% of the shares of Century Therapeutics Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31FMR Inc4.36050.00093612551-912078-20.1581
2023-12-31Casdin Capital, LLC3.87021.0449320638000
2024-03-31Boxer Capital LLC2.11230.3613175000017500000
2023-12-31BlackRock Inc1.83350.00011518996-76098-4.7708
2023-12-31Dafna Capital Management LLC1.57811.0401130740700
2024-03-31Avidity Partners Management LP1.47450.16461221555-133445-9.8483
2024-03-31Vanguard Group Inc1.37440.00011138653140001.2448
2024-03-31Baker Bros Advisors LP0.96260.041879746000
2023-12-31Federated Hermes Inc0.74650.005161848225000.4059
2024-03-31Octagon Capital Advisors LP0.65180.27055400005400000
2023-12-31Geode Capital Management, LLC0.56540.000246845737700.8113
2023-12-31State Street Corporation0.54130.000144849119200.4299
2024-03-31Millennium Management LLC0.43140.0006357401218441157.197
2024-03-31Jacobs Levy Equity Management, Inc.0.35480.005529394112265971.6123
2023-12-31Morgan Stanley - Brokerage Accounts0.33790.0001279928-44580-13.7377
2023-12-31Northern Trust Corp0.22450.0001185979-1215-0.6491
2024-03-31Charles Schwab Investment Management Inc0.18350.000215205132902.2116
2023-12-31Bridgeway Capital Management, LLC0.1450.0086120100-44900-27.2121
2023-12-31Renaissance Technologies Corp0.14390.00061192003150035.9179
2023-12-31Bank of New York Mellon Corp0.10930.0001905561395018.2101
Total 22.00142.945518227588+1489714+8.2%

3.2. Funds holding Century Therapeutics Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-03-31Fidelity Growth Compy Commingled Pl O1.93240.00831600920-24400-1.5012
2024-03-31Fidelity Growth Company Fund1.25820.00721042379-19222-1.8107
2024-04-30Vanguard Total Stock Mkt Idx Inv0.75850.000162842400
2024-03-31Fidelity Growth Company K60.66840.0121553755-1378-0.2482
2024-04-30iShares Russell 2000 ETF0.6460.0027535191-4277-0.7928
2024-03-31Federated Hermes Kaufmann Small Cap A0.40920.032733898000
2024-03-31Federated Hermes Kaufmann Small Cap Grow0.40920.032733898000
2024-04-30Vanguard Institutional Extnd Mkt Idx Tr0.36160.000929959700
2024-03-31Federated Hermes Kaufmann Growth0.32320.02226774500
2024-03-31Federated Hermes Kaufmann R0.32320.02226774500
2024-02-29Fidelity Small Cap Index0.2920.003424187635271.4798
2024-04-30iShares Russell 2000 Value ETF0.26940.005622323000
2024-04-30State St Russell Sm/Mid Cp® Indx NL Cl C0.19970.001216543400
2024-03-31Fidelity Series Growth Company0.19470.0042161300-7200-4.273
2024-03-31Fidelity Extended Market Index0.14880.001312327100
2024-03-31Bridgeway Ultra-Small Company Market0.12530.225210380000
2024-04-30Schwab US Small-Cap ETF™0.11940.00199895900
2024-04-30Vanguard Russell 2000 ETF0.10560.0027875263040.3485
2024-04-30State St Russell Sm Cap® Indx SL Cl I0.10440.00288646700
2024-04-30Vanguard Health Care ETF0.08520.00170574-161-0.2276
Total 8.73440.397236153-52807-0.7%

3.3. Insider Transactions

Insiders are holding 28.678% of the shares of Century Therapeutics Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-05-06Gregory RussottiSELL50003.12
2024-05-03Adrienne FaridSELL9133.11
2024-05-03Douglas CarrSELL2573.11
2024-04-22Gregory RussottiSELL50003.1
2024-03-07Adrienne FaridSELL228315.14
2024-02-05Adrienne FaridSELL20353.84
2024-02-05Douglas CarrSELL6433.84

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Century Therapeutics Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.083-0.298+261%-0.329+299%-0.003-96%0.113-173%
Book Value Per Share--2.1392.493-14%3.811-44%2.900-26%2.938-27%
Current Ratio--12.4389.818+27%12.800-3%10.389+20%9.296+34%
Debt To Asset Ratio--0.4900.458+7%0.363+35%0.557-12%0.568-14%
Debt To Equity Ratio--0.9590.852+13%0.573+67%0.936+2%1.074-11%
Dividend Per Share----0%-0%-0%-0%
Eps---0.337-0.401+19%-0.375+11%-0.315-7%-0.282-17%
Free Cash Flow Per Share---0.370-0.297-20%-0.401+8%-0.237-36%-0.173-53%
Free Cash Flow To Equity Per Share---0.151-0.272+80%-0.399+164%0.118-228%0.161-194%
Gross Profit Margin--1.0001.023-2%1.0000%1.005-1%0.899+11%
Intrinsic Value_10Y_max---13.501--------
Intrinsic Value_10Y_min---11.584--------
Intrinsic Value_1Y_max---1.086--------
Intrinsic Value_1Y_min---1.067--------
Intrinsic Value_3Y_max---3.467--------
Intrinsic Value_3Y_min---3.306--------
Intrinsic Value_5Y_max---6.092--------
Intrinsic Value_5Y_min---5.637--------
Market Cap249530400.000-39%347679024.000263254572.000+32%559156038.000-38%599362235.294-42%536271473.684-35%
Net Profit Margin---32.821-184.296+462%-28.753-12%-52.215+59%-46.718+42%
Operating Margin---36.619-161.557+341%-29.827-19%-47.113+29%-42.154+15%
Operating Ratio--37.619179.161-79%33.376+13%52.149-28%46.761-20%
Pb Ratio1.403-39%1.9551.317+48%1.723+13%1.682+16%1.505+30%
Pe Ratio-2.223+28%-3.097-2.024-35%-4.500+45%-5.359+73%-4.795+55%
Price Per Share3.000-39%4.1803.165+32%6.723-38%7.206-42%6.447-35%
Price To Free Cash Flow Ratio-2.026+28%-2.823-2.646-6%-4.164+47%-3.896+38%-3.486+23%
Price To Total Gains Ratio-36.338+28%-50.630-18.347-64%-20.202-60%-32.783-35%-32.783-35%
Quick Ratio--20.99116.188+30%21.419-2%16.720+26%14.960+40%
Return On Assets---0.081-0.088+9%-0.063-22%-0.065-20%-0.058-28%
Return On Equity---0.158-0.164+4%-0.099-37%-0.091-43%-0.081-49%
Total Gains Per Share---0.083-0.298+261%-0.329+299%-0.003-96%0.113-173%
Usd Book Value--177883000.000207358500.000-14%317017500.000-44%241199411.765-26%244345052.632-27%
Usd Book Value Change Per Share---0.083-0.298+261%-0.329+299%-0.003-96%0.113-173%
Usd Book Value Per Share--2.1392.493-14%3.811-44%2.900-26%2.938-27%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.337-0.401+19%-0.375+11%-0.315-7%-0.282-17%
Usd Free Cash Flow---30787000.000-24665250.000-20%-33362000.000+8%-19675823.529-36%-13662578.947-56%
Usd Free Cash Flow Per Share---0.370-0.297-20%-0.401+8%-0.237-36%-0.173-53%
Usd Free Cash Flow To Equity Per Share---0.151-0.272+80%-0.399+164%0.118-228%0.161-194%
Usd Market Cap249530400.000-39%347679024.000263254572.000+32%559156038.000-38%599362235.294-42%536271473.684-35%
Usd Price Per Share3.000-39%4.1803.165+32%6.723-38%7.206-42%6.447-35%
Usd Profit---28062000.000-33367750.000+19%-31170750.000+11%-26180352.941-7%-23424526.316-17%
Usd Revenue--855000.000342500.000+150%1465250.000-42%487588.235+75%75231263.158-99%
Usd Total Gains Per Share---0.083-0.298+261%-0.329+299%-0.003-96%0.113-173%
 EOD+3 -5MRQTTM+22 -12YOY+13 -205Y+8 -2610Y+9 -25

4.2. Fundamental Score

Let's check the fundamental score of Century Therapeutics Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-2.223
Price to Book Ratio (EOD)Between0-11.403
Net Profit Margin (MRQ)Greater than0-32.821
Operating Margin (MRQ)Greater than0-36.619
Quick Ratio (MRQ)Greater than120.991
Current Ratio (MRQ)Greater than112.438
Debt to Asset Ratio (MRQ)Less than10.490
Debt to Equity Ratio (MRQ)Less than10.959
Return on Equity (MRQ)Greater than0.15-0.158
Return on Assets (MRQ)Greater than0.05-0.081
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of Century Therapeutics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5045.281
Ma 20Greater thanMa 503.084
Ma 50Greater thanMa 1003.298
Ma 100Greater thanMa 2003.820
OpenGreater thanClose3.110
Total2/5 (40.0%)



Latest Balance Sheet

Balance Sheet of 2024-03-31. Currency in USD. All numbers in thousands.

Summary
Total Assets348,507
Total Liabilities170,624
Total Stockholder Equity177,883
 As reported
Total Liabilities 170,624
Total Stockholder Equity+ 177,883
Total Assets = 348,507

Assets

Total Assets348,507
Total Current Assets199,813
Long-term Assets148,694
Total Current Assets
Cash And Cash Equivalents 46,812
Short-term Investments 145,204
Other Current Assets 7,797
Total Current Assets  (as reported)199,813
Total Current Assets  (calculated)199,813
+/-0
Long-term Assets
Property Plant Equipment 88,319
Long Term Investments 57,852
Long-term Assets Other 544
Long-term Assets  (as reported)148,694
Long-term Assets  (calculated)146,715
+/- 1,979

Liabilities & Shareholders' Equity

Total Current Liabilities16,065
Long-term Liabilities154,559
Total Stockholder Equity177,883
Total Current Liabilities
Short-term Debt 2,215
Accounts payable 3,432
Other Current Liabilities 5,808
Total Current Liabilities  (as reported)16,065
Total Current Liabilities  (calculated)11,455
+/- 4,610
Long-term Liabilities
Capital Lease Obligations 46,466
Long-term Liabilities Other 20
Long-term Liabilities  (as reported)154,559
Long-term Liabilities  (calculated)46,486
+/- 108,073
Total Stockholder Equity
Common Stock6
Retained Earnings -683,833
Accumulated Other Comprehensive Income -241
Other Stockholders Equity 861,951
Total Stockholder Equity (as reported)177,883
Total Stockholder Equity (calculated)177,883
+/-0
Other
Capital Stock6
Cash and Short Term Investments 192,016
Common Stock Shares Outstanding 62,297
Current Deferred Revenue4,610
Liabilities and Stockholders Equity 348,507
Net Debt -346
Net Invested Capital 177,883
Net Working Capital 183,748
Property Plant and Equipment Gross 114,338
Short Long Term Debt Total 46,466



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312017-09-302016-12-312015-12-31
> Total Assets 
844,697
757,998
847,421
0
0
0
106,776
286,055
495,630
469,725
437,375
550,308
532,584
511,751
486,544
456,228
417,159
397,551
360,691
348,507
348,507360,691397,551417,159456,228486,544511,751532,584550,308437,375469,725495,630286,055106,776000847,421757,998844,697
   > Total Current Assets 
0
0
0
0
0
0
78,797
185,299
402,611
300,398
228,154
365,262
383,793
361,641
319,721
255,934
161,280
173,703
176,994
199,813
199,813176,994173,703161,280255,934319,721361,641383,793365,262228,154300,398402,611185,29978,797000000
       Cash And Cash Equivalents 
208
21,472
10,199
0
0
0
27,211
79,483
272,277
101,292
56,445
126,039
112,787
111,350
84,265
86,832
64,439
55,307
47,324
46,812
46,81247,32455,30764,43986,83284,265111,350112,787126,03956,445101,292272,27779,48327,21100010,19921,472208
       Short-term Investments 
0
0
0
0
0
0
48,542
103,459
125,290
193,860
166,434
234,981
265,971
244,509
231,233
164,637
91,958
114,198
125,414
145,204
145,204125,414114,19891,958164,637231,233244,509265,971234,981166,434193,860125,290103,45948,542000000
       Net Receivables 
0
0
0
0
0
0
908
137
137
191
250
247
284
364
780
1,465
1,706
1,665
665
0
06651,6651,7061,465780364284247250191137137908000000
       Other Current Assets 
4,932
4,390
9,700
0
0
0
256
269
3,511
2,714
250
1,245
4,751
5,418
3,443
4,465
4,883
4,198
3,591
7,797
7,7973,5914,1984,8834,4653,4435,4184,7511,2452502,7143,5112692560009,7004,3904,932
   > Long-term Assets 
0
0
0
0
0
0
27,979
100,756
93,019
169,327
209,221
185,046
148,791
150,110
166,823
200,294
255,879
223,848
183,697
148,694
148,694183,697223,848255,879200,294166,823150,110148,791185,046209,221169,32793,019100,75627,979000000
       Property Plant Equipment 
440,917
402,129
386,263
0
0
0
15,385
33,117
46,713
60,663
69,821
76,351
94,699
107,426
111,730
114,049
108,764
106,544
92,081
88,319
88,31992,081106,544108,764114,049111,730107,42694,69976,35169,82160,66346,71333,11715,385000386,263402,129440,917
       Long Term Investments 
0
0
0
0
0
0
1,053
63,138
42,474
105,193
135,914
105,360
50,607
39,427
51,854
83,316
144,581
114,762
89,096
57,852
57,85289,096114,762144,58183,31651,85439,42750,607105,360135,914105,19342,47463,1381,053000000
       Intangible Assets 
37,044
15,831
8,195
0
0
0
9,392
12,460
0
0
0
0
0
0
0
0
0
0
0
0
00000000000012,4609,3920008,19515,83137,044
       Long-term Assets Other 
0
0
0
0
0
0
1,240
1,240
3,832
3,471
3,486
3,335
3,485
3,257
3,239
2,929
2,534
2,542
541
544
5445412,5422,5342,9293,2393,2573,4853,3353,4863,4713,8321,2401,240000000
> Total Liabilities 
484,987
575,542
341,189
0
0
0
213,188
377,612
48,033
46,737
41,137
163,644
174,632
181,546
183,806
179,053
169,588
178,321
175,941
170,624
170,624175,941178,321169,588179,053183,806181,546174,632163,64441,13746,73748,033377,612213,188000341,189575,542484,987
   > Total Current Liabilities 
317,409
289,710
254,159
0
0
0
12,112
12,912
21,225
19,868
15,655
21,976
21,569
26,907
29,817
27,684
19,161
20,435
17,846
16,065
16,06517,84620,43519,16127,68429,81726,90721,56921,97615,65519,86821,22512,91212,112000254,159289,710317,409
       Short-term Debt 
0
0
0
0
0
0
240
596
594
640
1,654
592
2,316
4,541
6,977
10,297
1,183
2,040
1,513
2,215
2,2151,5132,0401,18310,2976,9774,5412,3165921,654640594596240000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
1,039
0
1,594
4,036
6,502
10,297
0
0
0
0
000010,2976,5024,0361,59401,0390000000000
       Accounts payable 
43,036
55,873
125,854
0
0
0
8,082
8,816
13,427
11,644
7,596
9,893
4,048
5,685
5,454
3,475
3,625
5,927
2,741
3,432
3,4322,7415,9273,6253,4755,4545,6854,0489,8937,59611,64413,4278,8168,082000125,85455,87343,036
       Other Current Liabilities 
136,458
90,399
118,719
0
0
0
52
337
1,034
1,082
1,082
5,112
7,381
9,110
10,232
7,412
7,417
8,597
9,220
5,808
5,8089,2208,5977,4177,41210,2329,1107,3815,1121,0821,0821,03433752000118,71990,399136,458
   > Long-term Liabilities 
0
0
0
0
0
0
201,076
364,700
26,808
26,869
25,482
141,668
153,063
154,639
153,989
151,369
150,427
157,886
158,095
154,559
154,559158,095157,886150,427151,369153,989154,639153,063141,66825,48226,86926,808364,700201,076000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
11,679
14,745
14,752
14,750
12,905
14,430
28,839
32,558
32,196
30,871
40,833
43,495
46,658
44,251
44,25146,65843,49540,83330,87132,19632,55828,83914,43012,90514,75014,75214,74511,679000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
855
2,268
2,254
2,020
1,470
1,220
971
718
433
361
201
56
20
20562013614337189711,2201,4702,0202,2542,2688550000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
2,119
0
0
0
0
0
0
0
0
0
0
0
0
0000000000002,1190000000
> Total Stockholder Equity
359,710
182,456
506,232
0
0
0
-106,412
-91,557
447,597
422,988
396,238
386,664
357,952
330,205
302,738
277,175
247,571
219,230
184,750
177,883
177,883184,750219,230247,571277,175302,738330,205357,952386,664396,238422,988447,597-91,557-106,412000506,232182,456359,710
   Common Stock
0
0
0
0
0
0
1
1
5
5
5
6
6
6
6
6
6
6
6
6
66666666655511000000
   Retained Earnings Total Equity000-583,652-550,362-519,098-487,416-456,667-425,679-388,166-359,972-333,96300000000
   Accumulated Other Comprehensive Income 
0
0
0
0
0
0
-3
-26
-3
-63
-650
-2,642
-3,434
-3,604
-2,462
-1,275
-1,208
-1,304
108
-241
-241108-1,304-1,208-1,275-2,462-3,604-3,434-2,642-650-63-3-26-3000000
   Capital Surplus 
0
0
0
0
0
0
0
0
781,558
783,018
785,049
814,979
818,047
821,219
824,292
828,806
832,425
0
0
0
000832,425828,806824,292821,219818,047814,979785,049783,018781,55800000000
   Treasury Stock00000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
185,932
219,158
781,558
783,018
785,049
814,979
818,047
821,219
824,292
828,806
832,425
836,901
840,407
861,951
861,951840,407836,901832,425828,806824,292821,219818,047814,979785,049783,018781,558219,158185,932000000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue2,235
Cost of Revenue-13,044
Gross Profit-10,809-10,809
 
Operating Income (+$)
Gross Profit-10,809
Operating Expense-114,372
Operating Income-125,181-125,181
 
Operating Expense (+$)
Research Development92,710
Selling General Administrative34,706
Selling And Marketing Expenses13,044
Operating Expense114,372140,460
 
Net Interest Income (+$)
Interest Income12,677
Interest Expense-540
Other Finance Cost-6,267
Net Interest Income5,870
 
Pretax Income (+$)
Operating Income-125,181
Net Interest Income5,870
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-134,792-115,570
EBIT - interestExpense = -125,721
-134,792
-136,133
Interest Expense540
Earnings Before Interest and Taxes (EBIT)-125,181-134,252
Earnings Before Interest and Taxes (EBITDA)-112,137
 
After tax Income (+$)
Income Before Tax-134,792
Tax Provision-2,782
Net Income From Continuing Ops-128,957-137,574
Net Income-136,673
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses127,416
Total Other Income/Expenses Net-9,611-5,870
 

Technical Analysis of Century Therapeutics Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Century Therapeutics Inc. The general trend of Century Therapeutics Inc is BEARISH with 28.6% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Century Therapeutics Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-28.6%) Bearish trend (28.6%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Century Therapeutics Inc.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 3.449 < 3.47 < 3.51.

The bearish price targets are: 2.9 > 2.86 > 2.75.

Tweet this
Century Therapeutics Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Century Therapeutics Inc. The current mas is .

The long score for the Moving Averages is 5/14.
The longshort score for the Moving Averages is -4/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Century Therapeutics Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Century Therapeutics Inc. The current macd is -0.06969756.

The long score for the Moving Average Convergence/Divergence (MACD) is 2/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 0/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Century Therapeutics Inc price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Century Therapeutics Inc. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Century Therapeutics Inc price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Century Therapeutics Inc Daily Moving Average Convergence/Divergence (MACD) ChartCentury Therapeutics Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Century Therapeutics Inc. The current adx is 18.13.

The long score for the Directional Movement Index (DMI) is 1/7.
The longshort score for the Directional Movement Index (DMI) is 1/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Century Therapeutics Inc shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Century Therapeutics Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Century Therapeutics Inc. The current sar is 3.53261433.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Century Therapeutics Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Century Therapeutics Inc. The current rsi is 45.28. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Century Therapeutics Inc Daily Relative Strength Index (RSI) ChartCentury Therapeutics Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Century Therapeutics Inc. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -4/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Century Therapeutics Inc price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Century Therapeutics Inc Daily Stochastic Oscillator ChartCentury Therapeutics Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Century Therapeutics Inc. The current cci is -109.75542248.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Century Therapeutics Inc Daily Commodity Channel Index (CCI) ChartCentury Therapeutics Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Century Therapeutics Inc. The current cmo is -10.27977778.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Century Therapeutics Inc Daily Chande Momentum Oscillator (CMO) ChartCentury Therapeutics Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Century Therapeutics Inc. The current willr is -75.80645161.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Century Therapeutics Inc is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Century Therapeutics Inc Daily Williams %R ChartCentury Therapeutics Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Century Therapeutics Inc.

Century Therapeutics Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Century Therapeutics Inc. The current atr is 0.30958256.

Century Therapeutics Inc Daily Average True Range (ATR) ChartCentury Therapeutics Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Century Therapeutics Inc. The current obv is -10,834,851.

Century Therapeutics Inc Daily On-Balance Volume (OBV) ChartCentury Therapeutics Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Century Therapeutics Inc. The current mfi is 51.86.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Century Therapeutics Inc Daily Money Flow Index (MFI) ChartCentury Therapeutics Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Century Therapeutics Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-01-17SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-22SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-23RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-01-24STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-25MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-26MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-30STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-31RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-01CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-02SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-02-06SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-12STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-15STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-21DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-22CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-26WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-04CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-05DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-03-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-07BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-14CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-25DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-01STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-02CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-11DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-15STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-16DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-22WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-24STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-26STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-29DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-30STOCH LONG EXITThe %K line crosses below the %D line.
2024-05-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-05-07SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-05-08STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-05-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-05-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-05-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-05-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-05-17WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-05-20SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-05-22STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-05-23STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-05-28STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-05-30STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-05-31WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-06-03CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-06-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-06-05STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside

6.3. Candlestick Patterns

Century Therapeutics Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Century Therapeutics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5045.281
Ma 20Greater thanMa 503.084
Ma 50Greater thanMa 1003.298
Ma 100Greater thanMa 2003.820
OpenGreater thanClose3.110
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Century Therapeutics Inc with someone you think should read this too:
  • Are you bullish or bearish on Century Therapeutics Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Century Therapeutics Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Century Therapeutics Inc

I send you an email if I find something interesting about Century Therapeutics Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Century Therapeutics Inc.

Receive notifications about Century Therapeutics Inc in your mailbox!